These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 34372691)
1. Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance. Zhu Z; Antenucci F; Villumsen KR; Bojesen AM mBio; 2021 Aug; 12(4):e0170721. PubMed ID: 34372691 [TBL] [Abstract][Full Text] [Related]
2. Outer Membrane Vesicles Protect Gram-Negative Bacteria against Host Defense Peptides. Balhuizen MD; van Dijk A; Jansen JWA; van de Lest CHA; Veldhuizen EJA; Haagsman HP mSphere; 2021 Aug; 6(4):e0052321. PubMed ID: 34232080 [TBL] [Abstract][Full Text] [Related]
3. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8 Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032 [TBL] [Abstract][Full Text] [Related]
4. Rapid prototyping vaccine approach in mice against multi-drug resistant Gram-negative organisms from clinical isolates based on outer membrane vesicles. Pritsch M; Ben Khaled N; Liegl G; Schubert S; Hoelscher M; Woischke C; Arens N; Thorn-Seshold J; Kammermeier S; Wieser A Microbiol Immunol; 2021 May; 65(5):214-227. PubMed ID: 33650163 [TBL] [Abstract][Full Text] [Related]
5. On-Demand Vaccine Production via Dock-and-Display of Biotinylated Antigens on Bacterial Extracellular Vesicles. Weyant KB; Oloyede A; DeLisa MP Methods Mol Biol; 2024; 2843():195-216. PubMed ID: 39141302 [TBL] [Abstract][Full Text] [Related]
7. Vaccination with outer membrane vesicles and the fimbrial protein FlfA offers improved protection against lesions following challenge with Gallibacterium anatis. Persson G; Pors SE; Thøfner ICN; Bojesen AM Vet Microbiol; 2018 Apr; 217():104-111. PubMed ID: 29615242 [TBL] [Abstract][Full Text] [Related]
8. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215 [TBL] [Abstract][Full Text] [Related]
10. Proteome-minimized outer membrane vesicles from Zanella I; König E; Tomasi M; Gagliardi A; Frattini L; Fantappiè L; Irene C; Zerbini F; Caproni E; Isaac SJ; Grigolato M; Corbellari R; Valensin S; Ferlenghi I; Giusti F; Bini L; Ashhab Y; Grandi A; Grandi G J Extracell Vesicles; 2021 Feb; 10(4):e12066. PubMed ID: 33643549 [TBL] [Abstract][Full Text] [Related]
11. OMV Vaccines and the Role of TLR Agonists in Immune Response. Mancini F; Rossi O; Necchi F; Micoli F Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575921 [TBL] [Abstract][Full Text] [Related]
12. [Advances in outer membrane vesicles of gram-negative bacteria as sub-unit vaccines - A review]. Yi J; Liu Q; Kong Q Wei Sheng Wu Xue Bao; 2016 Jun; 56(6):911-21. PubMed ID: 29727152 [TBL] [Abstract][Full Text] [Related]
13. Outer membrane vesicles of Gallibacterium anatis induce protective immunity in egg-laying hens. Pors SE; Pedersen IJ; Skjerning RB; Thøfner ICN; Persson G; Bojesen AM Vet Microbiol; 2016 Nov; 195():123-127. PubMed ID: 27771057 [TBL] [Abstract][Full Text] [Related]
14. Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens. Lei EK; Azmat A; Henry KA; Hussack G Appl Microbiol Biotechnol; 2024 Feb; 108(1):232. PubMed ID: 38396192 [TBL] [Abstract][Full Text] [Related]
15. Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification. Gerritzen MJH; Salverda MLM; Martens DE; Wijffels RH; Stork M Vaccine; 2019 Nov; 37(47):6978-6986. PubMed ID: 31383485 [TBL] [Abstract][Full Text] [Related]
16. Bacterial outer membrane vesicles as a platform for biomedical applications: An update. Li M; Zhou H; Yang C; Wu Y; Zhou X; Liu H; Wang Y J Control Release; 2020 Jul; 323():253-268. PubMed ID: 32333919 [TBL] [Abstract][Full Text] [Related]
17. Outer Membrane Vesicles (OMVs) Produced by Gram-Negative Bacteria: Structure, Functions, Biogenesis, and Vaccine Application. Furuyama N; Sircili MP Biomed Res Int; 2021; 2021():1490732. PubMed ID: 33834062 [TBL] [Abstract][Full Text] [Related]
18. Glycoengineered Outer Membrane Vesicles as a Platform for Vaccine Development. Valguarnera E; Feldman MF Methods Enzymol; 2017; 597():285-310. PubMed ID: 28935107 [TBL] [Abstract][Full Text] [Related]
19. Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen. Bottero D; Zurita ME; Gaillard ME; Bartel E; Vercellini C; Hozbor D Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29180369 [No Abstract] [Full Text] [Related]
20. Bacterial outer membrane vesicles as a candidate tumor vaccine platform. Wang S; Guo J; Bai Y; Sun C; Wu Y; Liu Z; Liu X; Wang Y; Wang Z; Zhang Y; Hao H Front Immunol; 2022; 13():987419. PubMed ID: 36159867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]